Cart

“Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF” has been added to your cart. View cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item	Thumbnail image	Product	Price	Quantity	Subtotal
×		Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF	$40.00	Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF quantity	$40.00
×		Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF	$40.00	Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF quantity	$40.00
×		De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF	$40.00	De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF quantity	$40.00
×		Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices PDF	$40.00	Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices PDF quantity	$40.00
×		Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF	$40.00	Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF quantity	$40.00
×		The Safety of Olanzapine Compared With Other Antipsychotic Drugs: Results of an Observational Prospective Study in Patients With Schizophrenia (EFESO Study) PDF	$40.00	The Safety of Olanzapine Compared With Other Antipsychotic Drugs: Results of an Observational Prospective Study in Patients With Schizophrenia (EFESO Study) PDF quantity	$40.00
×		The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials PDF	$40.00	The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials PDF quantity	$40.00
×		Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF	$40.00	Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF quantity	$40.00
Coupon:

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.

Cart totals

Subtotal	$320.00
Total	$320.00

Proceed to checkout